Abstract
Background
There is considerable variability in rates of hospitalization of patients with community-acquired pneumonia, in part because of physicians' uncertainty in assessing the severity of illness at presentation.Methods
From our analysis of data on 14,199 adult inpatients with community-acquired pneumonia, we derived a prediction rule that stratifies patients into five classes with respect to the risk of death within 30 days. The rule was validated with 1991 data on 38,039 inpatients and with data on 2287 inpatients and outpatients in the Pneumonia Patient Outcomes Research Team (PORT) cohort study. The prediction rule assigns points based on age and the presence of coexisting disease, abnormal physical findings (such as a respiratory rate of > or = 30 or a temperature of > or = 40 degrees C), and abnormal laboratory findings (such as a pH <7.35, a blood urea nitrogen concentration > or = 30 mg per deciliter [11 mmol per liter] or a sodium concentration <130 mmol per liter) at presentation.Results
There were no significant differences in mortality in each of the five risk classes among the three cohorts. Mortality ranged from 0.1 to 0.4 percent for class I patients (P=0.22), from 0.6 to 0.7 percent for class II (P=0.67), and from 0.9 to 2.8 percent for class III (P=0.12). Among the 1575 patients in the three lowest risk classes in the Pneumonia PORT cohort, there were only seven deaths, of which only four were pneumonia-related. The risk class was significantly associated with the risk of subsequent hospitalization among those treated as outpatients and with the use of intensive care and the number of days in the hospital among inpatients.Conclusions
The prediction rule we describe accurately identifies the patients with community-acquired pneumonia who are at low risk for death and other adverse outcomes. This prediction rule may help physicians make more rational decisions about hospitalization for patients with pneumonia.References
Articles referenced by this article (41)
Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact.
Am J Med, (6B):32-37 1985
MED: 4014285
Management of pneumonia in the prospective payment era. A need for more clinician and support service interaction.
Arch Intern Med, (7):1392-1397 1984
MED: 6539581
Community-acquired lower respiratory tract infections. Prevention and cost-control strategies.
Am J Med, (6B):52-57 1985
MED: 4014288
Title not supplied
Using diagnosis-related groups for studying variations in hospital admissions.
Health Care Financ Rev, (4):53-62 1988
MED: 10312632
Are hospital services rationed in New Haven or over-utilised in Boston?
Lancet, (8543):1185-1189 1987
MED: 2883497
Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study.
Am J Med, (6):713-721 1990
MED: 2252039
Title not supplied
Q J Med 1987
Predicting hospital-associated mortality for Medicare patients. A method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure.
JAMA, (24):3617-3624 1988
MED: 3057251
Predicting death in patients hospitalized for community-acquired pneumonia.
Ann Intern Med, (6):428-436 1991
MED: 1872491
Show 10 more references (10 of 41)
Citations & impact
Impact metrics
Article citations
Impact of antibiotic changes on hospital stay and treatment duration in community-acquired pneumonia.
Sci Rep, 14(1):22669, 30 Sep 2024
Cited by: 0 articles | PMID: 39349548 | PMCID: PMC11442439
Patients with influenza admitted to a tertiary-care hospital in Riyadh between 2018 and 2022: characteristics, outcomes and factors associated with ICU admission and mortality.
BMC Pulm Med, 24(1):464, 19 Sep 2024
Cited by: 0 articles | PMID: 39300448 | PMCID: PMC11414087
Insights into the baseline blood pH homeostasis at admission and the risk of in-hospital mortality in COVID-19 patients.
Biomark Med, 18(19):795-800, 10 Sep 2024
Cited by: 0 articles | PMID: 39255012
Increased plasma AACT level as an indicator of poor prognosis in patients hospitalised with community-acquired pneumonia: a multicentre prospective cohort study.
BMC Infect Dis, 24(1):946, 09 Sep 2024
Cited by: 0 articles | PMID: 39251931 | PMCID: PMC11384707
A Simple Score (MOG-AR) to Identify Individuals at High Risk of Relapse After MOGAD Attack.
Neurol Neuroimmunol Neuroinflamm, 11(6):e200309, 09 Sep 2024
Cited by: 0 articles | PMID: 39250723 | PMCID: PMC11385954
Go to all (2,387) article citations
Other citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.
Am J Med, 118(4):384-392, 01 Apr 2005
Cited by: 167 articles | PMID: 15808136
The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study.
Arch Intern Med, 157(1):36-44, 01 Jan 1997
Cited by: 114 articles | PMID: 8996039
[CCERW: a new rule to predict treatment failure in patients with community-acquired pneumonia in middle aged and elderly people].
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 23(1):10-17, 01 Jan 2011
Cited by: 0 articles | PMID: 21251359
Assessment of severity of community-acquired pneumonia.
Semin Respir Infect, 14(2):103-114, 01 Jun 1999
Cited by: 7 articles | PMID: 10391405
Review